DIVIDEND ANNOUNCEMENT: Gilead Sciences Inc (NASDAQ:GILD) on 07/30/2020 declared a dividend of $0.6800 per share

Gilead Sciences Inc (NASDAQ:GILD) on 07/30/2020 declared a dividend of $ 0.6800 per share payable on September 29, 2020 to shareholders of record as of September 15, 2020.

Gilead Sciences Inc (NASDAQ:GILD) has paid dividends since 2015, has a current dividend yield of 3.7255170345% and has increased its dividends for 4 successive years.

Gilead Sciences Inc's market cap is $ 91,581,772,730 and has a PE ratio of 18.77. The stock price closed yesterday at $ 73.01 and has a 52 week low/high of $ 60.89 and $ 85.97.

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory and fibrotic diseases and oncology. Co.'s products include: Biktarvy for the treatment of HIV-1 infection in certain patients; Vosevi®, a single tablet regimen of sofosbuvir, velpatasvir and voxilaprevir for the re-treatment of chronic hepatitis C virus infection in adults; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; and Yescarta (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

For more information on Gilead Sciences Inc click here.